Skip to main content
Figure 1 | BMC Nephrology

Figure 1

From: Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria

Figure 1

Polypeptide patterns of patients with diabetes type 2 before and after 2-year treatment (Irbesartan and placebo) examined in the 'IRMA2' study. Shown are compiled patterns consisting of all samples from each of the four groups. The molecular mass (0.7 to 15 kDa, on a logarithmic scale) is plotted against normalized migration time (17 to 47 min). Signal intensity is encoded by peak height and color.

Back to article page